Enterprise Europe Network

MEDICA Healthcare Brokerage Event 2026

16 – 29 Nov 2026 | Düsseldorf, Germany

Register
Register
Register

ProductUpdated on 16 October 2026

Competitive Patent Early Warning & Landscaping: An Enterprise-Grade SaaS Service

CEO at Intellisemantic

Rivoli, Italy

About

We provide a dedicated, enterprise-grade SaaS platform that bridges the gap between R&D innovation and Intellectual Property (IP) management. In the fast-evolving medical device and healthcare sectors, staying ahead of competitor filings is critical.

Our solution acts as a company-specific repository and an early-warning system, automatically monitoring third-party patent applications. It allows life sciences companies and medical corporations to systematically track technological trends, evaluate competitor strategies, and safeguard their own R&D pipelines from infringement risks before investing significant capital.

The Problem Solved

  • Blind Spots in R&D: Mitigates the risk of overlapping research by providing an early warning of third-party patent applications that could impact product development timelines.

  • Complex Competitor Tracking: Simplifies the overwhelming task of analyzing complex global patent trends and technology landscapes.

  • Siloed Internal Communication: Resolves the traditional disconnect between R&D engineers (tech experts) and IP managers (legal experts) by providing a unified collaborative workspace.

Key Features & Innovation

  • Scalable Private Repository: Supports dedicated hosting of 10,000+ competitive patents of interest (expandable on demand).

  • Dual-User Architecture: Tailored interfaces and workflows specifically built for two distinct user categories: IP Managers and R&D Experts.

  • Customizable Categorization: Allows companies to organize patents by custom criteria (e.g., specific medical technology, clinical application, or competitor) to facilitate global trend analysis.

  • Semantic Retrieval & Search: Empowers users to find relevant prior art and related patents quickly without needing complex Boolean strings.

  • Collaborative Tools: Features native annotation, scoring, and evaluation tools to streamline communication and speed up decision-making between legal and technical teams.

Target Audience & Ideal Partners

Our primary targets are corporate enterprises and medium-to-large medical organizations systematically engaged in medical device development, pharmaceutical R&D, and biotechnology patenting.

Looking for

  • Buyer

Applies to

  • E-HEALTH
  • INDUSTRIAL BIOTECHNOLOGY
  • MICRO- AND NANOTECHNOLOGY
  • ROBOTICS AND AUTOMATION
  • THERAPEUTIC AREA

Organisation

Intellisemantic

Research & Development (company)

Rivoli, Italy

Similar opportunities